Page last updated: 2024-08-24

2',3'-dideoxyadenosine triphosphate and 2'-deoxyadenosine triphosphate

2',3'-dideoxyadenosine triphosphate has been researched along with 2'-deoxyadenosine triphosphate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harada, S; Mitsuya, H; Wang, R; Zemlicka, J1
Amblard, F; Bassit, L; Bondada, L; Coats, SJ; Detorio, M; Grier, J; Hernandez-Santiago, BI; Koontz, D; Mellors, JW; Rapp, KL; Schinazi, RF; Sluis-Cremer, N1
Johnson, KA; Suo, Z1
Hori, K; Mori, K; Ogasawara, H; Saito, K; Takahashi, K; Takahashi, S1
Babusis, D; Durand-Gasselin, L; Flaherty, JF; Hawkins, T; Ray, AS; Reddy, YS; Veikley, W1
Baev, D; Cahn, P; Calarota, SA; De Forni, D; Katabira, E; Lori, F; Maserati, R; Rakhmanova, A; Stevens, MR; Testori, M1

Trials

2 trial(s) available for 2',3'-dideoxyadenosine triphosphate and 2'-deoxyadenosine triphosphate

ArticleYear
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Adenine; Adult; Aged; Anti-HIV Agents; Chromatography, Liquid; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; Didanosine; Dideoxynucleotides; Female; HIV Infections; Humans; Male; Middle Aged; Nucleotides; Organophosphonates; Tandem Mass Spectrometry; Tenofovir; Young Adult

2011
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Adult; Analysis of Variance; Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Delayed-Action Preparations; Deoxyadenine Nucleotides; Didanosine; Dideoxynucleotides; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Immunomodulation; Male; Placebos; RNA, Viral; Urea; Viral Load

2012

Other Studies

4 other study(ies) available for 2',3'-dideoxyadenosine triphosphate and 2'-deoxyadenosine triphosphate

ArticleYear
Inhibition of human immunodeficiency virus reverse transcriptase by synadenol triphosphate and its E-isomer.
    Journal of medicinal chemistry, 2003, Oct-23, Volume: 46, Issue:22

    Topics: Anti-HIV Agents; HIV Reverse Transcriptase; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Stereoisomerism

2003
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors

2009
Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
    The Journal of biological chemistry, 1998, Oct-16, Volume: 273, Issue:42

    Topics: Adenine; Animals; Anti-HIV Agents; Deoxyadenine Nucleotides; Dideoxynucleotides; DNA Polymerase beta; HIV Reverse Transcriptase; Kinetics; Models, Chemical; Organophosphonates; Organophosphorus Compounds; Rats; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir

1998
Identification of a domain conferring nucleotide binding to the N-acetyl-d-glucosamine 2-epimerase (Renin binding protein).
    Journal of biochemistry, 2002, Volume: 131, Issue:4

    Topics: Adenosine Triphosphate; Animals; Blotting, Western; Carbohydrate Epimerases; Carrier Proteins; Catalytic Domain; Deoxyadenine Nucleotides; Dideoxynucleotides; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Humans; Models, Molecular; Nucleotides; Plasmids; Protein Structure, Tertiary; Rats; Renin; Thermolysin

2002